NCT01268059 A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01263782 BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01256268 Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids Status COMPLETED Phase PHASE1
NCT01251874 Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01249443 Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection Status TERMINATED Phase PHASE1
NCT01248962 Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT01248949 A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01239732 A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer Status COMPLETED Phase PHASE3
NCT01238133 Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer Status TERMINATED Phase PHASE1
NCT01237067 Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers Status COMPLETED Phase PHASE1
NCT01234038 Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel Status COMPLETED Phase PHASE1/PHASE2
NCT01233843 Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. Status COMPLETED Phase PHASE3
NCT01229930 Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT01225302 A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1
NCT01221753 Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study Status TERMINATED Phase PHASE2
NCT01220154 Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer Status COMPLETED Phase PHASE1
NCT01219777 Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian Status COMPLETED Phase PHASE1
NCT01218516 A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung Status COMPLETED Phase PHASE2
NCT01213381 Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01209520 Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy Status COMPLETED Phase NA